Here’s the back story behind a $100M fund raiser for Chimerix: A growing oncology pipeline
The pipeline of cancer drug developer Chimerix is growing, and the biotech has raised $100 million to support it. NCBiotech writer Frank Vinluan has he full story.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
